Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis

A significant proportion of patients with multiple sclerosis who receive interferon beta (IFNβ) therapy develop neutralizing antibodies (NAbs) that reduce drug efficacy. To investigate if HLA class I and II alleles are associated with development of NAbs against IFNβ we analyzed whether NAb status a...

Descripción completa

Detalles Bibliográficos
Autores principales: Link, Jenny, Lundkvist Ryner, Malin, Fink, Katharina, Hermanrud, Christina, Lima, Izaura, Brynedal, Boel, Kockum, Ingrid, Hillert, Jan, Fogdell-Hahn, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946519/
https://www.ncbi.nlm.nih.gov/pubmed/24608124
http://dx.doi.org/10.1371/journal.pone.0090479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946519/
https://www.ncbi.nlm.nih.gov/pubmed/24608124
http://dx.doi.org/10.1371/journal.pone.0090479

Ejemplares similares